Discover Research Beta

Browse peer-reviewed articles from Medwin Publishers' open access journals.

Clear Filters

Showing 151–180 of 11,616 articles

"Li J" ×
PDRAJ Short Communication Sep 2, 2026
Green Pharmaceutical Manufacturing: Strategies for Sustainable and Resource-Efficient Pharmaceutical Production
Chung P*

The pharmaceutical industry is increasingly expected to improve environmental sustainability while maintaining stringent standards of product quality and manufacturing reliabilit…

Green Pharmaceutical Manufacturing Sustainability Green Chemistry
PDRAJ Editorial Sep 2, 2026
From Molecule to Meaning: Why Drug Discovery Needs a New Human-Centered Framework
Suresh R*

Drug discovery is increasingly moving beyond a molecule-centered model toward approaches that place human biology, patient needs, and meaningful clinical outcomes at the center o…

Drug Discovery Human-Cantered Drug Development
PDRAJ Opinion Sep 2, 2026
Drug Repurposing as a Strategic Approach to Accelerate Therapeutic Innovation
Miller D*

Drug development is characterized by substantial financial investment, lengthy timelines, and high attrition rates between discovery and regulatory approval. Drug repurposing, al…

Drug Repurposing Drug Repositioning Therapeutic Innovation
WHSJ Perspective Sep 2, 2026
Spontaneous Bilateral Ectopic Pregnancy in a Natural Cycle: Diagnostic Challenges and Fertility-Preserving Laparoscopic Management
Bilateral Ectopic Pregnancy Natural Conception Laparoscopic Salpingostomy
OAJAR Opinion Sep 2, 2026
Powering Every Drop: An Opinion on Artificial Intelligence and Solar Smart Irrigation for Climate-Resilient Agriculture
Howard B*

Agriculture is facing increasing pressure to produce more food with fewer natural resources while adapting to climate change and environmental degradation. Water scarcity, rising…

Artificial Intelligence Smart Irrigation Solar Energy
PDRAJ Editorial Sep 2, 2026
From Therapeutic Discovery to Lasting Impact: Reimagining the Modern Pathway of Medicine Development
Suresh R*

The pathway from therapeutic discovery to meaningful patient benefit is undergoing a fundamental transformation. Conventional medicine development has traditionally followed a se…

Drug Development Therapeutic Discovery Precision Medicine
APCT Opinion Sep 2, 2026
Beyond the Trial Endpoint: Why Drug Development Must Listen to Patients
James*
Drug Development: Toxicology: drug trials:
PDRAJ Editorial Sep 2, 2026
Artificial Intelligence in Pharmaceutical Manufacturing: Transforming Quality, Efficiency, and Process Control
Pandey P*

The pharmaceutical industry is entering a period of significant technological transformation. Artificial intelligence (AI), machine learning, advanced analytics, and automation a…

Artificial Intelligence Pharmaceutical Manufacturing Machine Learning
OAJAR Perspective Sep 2, 2026
Cultivating the Autonomous Farm: Integrating Agricultural Robotics, Artificial Intelligence, and Precision Automation for Sustainable Crop Production
Busch H*

The increasing demand for food, coupled with climate change, labor shortages, and diminishing natural resources, has accelerated the adoption of advanced technologies in agricult…

Agricultural Robotics Automation Sustainable Agriculture
OAJPR Mini Review Sep 2, 2026
Selective Organ Targeting (SORT) Lipid Nanoparticles for Extrahepatic mRNA Delivery: Biophysical Mechanisms and Clinical Horizons
Lipid Nanoparticles mRNA Delivery Selective Organ Targeting
OAJPR Perspective Sep 2, 2026
Artificial Intelligence in Pharmaceutical Drug Discovery and Development
Artificial intelligence machine learning drug discovery
IJSST Mini Review Sep 2, 2026
Artificial Intelligence Meets Surgical Robotics: From Robotic Assistance to Supervised Surgical Autonomy
Pereira D*

Artificial intelligence (AI) is changing the role of surgical robotics from mechanically precise instruments toward increasingly intelligent systems capable of recognizing anatom…

Artificial Intelligence Robotic Surgery Autonomous Surgery
PDRAJ Short Communication Sep 2, 2026
Beyond Efficacy: Rethinking Safety, Accessibility, and Equity in Contemporary Drug Development
Abdulhussain S, Muhamad R and Fiza Q*

Contemporary drug development increasingly requires a broader assessment of therapeutic value than efficacy alone. Although demonstrating clinical efficacy remains fundamental, m…

Drug Development Clinical Efficacy Drug Safety
PDRAJ Opinion Sep 2, 2026
When Therapeutic Evidence Meets Patient Reality: Reframing the Value of Medicines Beyond the Prescription
Hang Q*

The value of a medicine is often defined primarily through evidence of efficacy and safety generated during clinical development. perform in everyday healthcare. However, the ex…

Therapeutic Value Medicines Patient-Centred Care
OAJAR Mini Review Sep 2, 2026
Cultivating Living Soils: Harnessing Biofertilizers and Soil Microbiomes for the Next Generation of Sustainable Crop Production
Berg PVD*

The increasing demand for sustainable agricultural production has accelerated the adoption of environmentally friendly technologies that improve crop productivity while maintaini…

Biofertilizers Soil Microbiome Sustainable Agriculture
PDRAJ Short Communication Sep 2, 2026
The Intelligent Patient Journey: Artificial Intelligence as the Foundation of Precision Healthcare
Rathod S*

Clinical trials remain the foundation for evaluating the efficacy and safety of medicines, but their controlled conditions cannot fully represent the complexity of routine health…

Real-World Evidence Clinical Trials Real-World Data
OAJAR Perspective Sep 2, 2026
Designing the Next Generation of Crop Improvement: Integrating Microbiomes, Biofertilizers, and Gene Editing for Sustainable Agriculture
Navarro S

Global agriculture is under increasing pressure to produce higher-quality food while facing climate change, declining soil fertility, and limited natural resources. Agricultural …

Agricultural Biotechnology Crop Yield Crop Quality
OAJPR Opinion Sep 2, 2026
Nanotechnology-Based Drug Delivery Systems: Advances and Pharmaceutical Applications
Nanotechnology nanoparticles drug delivery
PDRAJ Short Communication Sep 2, 2026
When Medicines Become Data: Reimagining the Drug Development Continuum in an Era of Precision Therapeutics
Nick K*

The contemporary drug development landscape is increasingly shaped by the ability to generate, integrate, and interpret large volumes of biological and clinical information. Medi…

Drug Development Precision Therapeutics Pharmaceutical Innovation
PDRAJ Opinion Sep 2, 2026
The Broken Promise of Accelerated Approval: Reforming Post Marketing Confirmatory Trials and Dangling Indications
Vance A*

The Accelerated Approval pathway, established in 1992 under 21 CFR 314 Subpart H, was created to expedite patient access to promising therapeutics for serious or life-threatening…

Accelerated Approval Confirmatory Trials FDORA
PDRAJ Short Communication Sep 2, 2026
Closing the Treatment-to-Outcome Gap: Emerging Evidence on How Medicines Perform in Everyday Care
Zhou A*

The effectiveness of a medicine in routine healthcare can differ from the efficacy demonstrated under the controlled conditions of clinical trials. This treatment-to-outcome gap …

Real-World Evidence Real-World Data Drug Effectiveness
WHSJ Policy Article Sep 1, 2026
Eliminating Preventable Maternal Mortality: Scaling Non- Pneumatic Anti-Shock Garments for Community-Level Obstetric Hemorrhage
Postpartum Hemorrhage Non-Pneumatic Anti-Shock Garment NASG
WHSJ Opinion Sep 1, 2026
Rethinking Polycystic Ovary Syndrome: Why Metabolic Subtyping Must Supersede the Rotterdam Criteria in Clinical Practice
Polycystic Ovary Syndrome Rotterdam Criteria Metabolic Subtyping

Page 6 of 388